Yseop Joins Veevas AI Partner Program To Accelerate Regulatory Document Writing And AI-Driven Content Automation

Yseop Copilot integrates with Veeva Vault RIM for one-click document generation in medical writing

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Yseop, a leader in artificial intelligence (AI) enterprise software, is excited to announce it has joined the Veeva AI Partner Program. As a Veeva AI partner, Yseop is helping to transform the regulatory document workflow process — from data ingestion, authoring, and content development to validation and submission —accelerating the time it takes to bring new drugs to market.

Yseop Copilot empowers regulatory teams and medical writers with AI-driven content workflow automation, boosting productivity and efficiency for regulatory documents. The integration between Yseop Copilot and Veeva Vault RIM will further enable mutual life sciences customers to improve visibility, data quality, and agility, and accelerate medical writing workflows. Biopharmas using Vault RIM for regulatory content management will be able to benefit from Yseop Copilot’s intelligent Generative AI capabilities, enabling single-click document creation and management.

“Veeva’s leadership in the Biopharma software space makes this integration a significant milestone, further extending Yseop Copilot’s reach across the life sciences sector,” said Emmanuel Walckenaer, CEO of Yseop. “We’re proud to contribute to Veeva’s AI Partner Program, enhancing their regulatory content management experience and helping the industry reduce time to market while allowing medical writers to operate more efficiently within familiar workflows.”

“A significant part of Veeva's AI strategy is ensuring customers have access to AI applications that work seamlessly with the Veeva Vault platform, such as Yseop,” said Marc Gabriel, Vice President, Veeva Vault RIM. “By collaborating with Yseop, our complementary technologies can speed regulatory document writing and workflows so mutual customers can streamline the regulatory documentation process.”

Yseop is proud to sponsor Veeva R&D and Quality Summit in Boston, September 9-10. Key topics include enhancing clinical operations, optimizing clinical data, and improving regulatory submissions to boost efficiency and productivity. For more information about our integration with Veeva or to request a meeting at the Veeva R&D and Quality Summit, please contact us here.

About Yseop
Yseop is the leader in Generative AI for life science and pharmaceutical companies, changing the way content automation solutions are delivered with a human-centric, AI platform. Yseop is a pioneer in Natural Language Processing (NLP) technology and acts as a “Copilot” for medical writers, maximizing their efficiency and accuracy in generating reports and insights crucial to drug development and approval.

Media Contacts
FischTank PR
yseop@fischtankpr.com

First published on Fri, Sep 6, 2024

Enjoyed what you've read so far? Great news - there's more to explore!

Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.

Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.

Dive into TechDogs' treasure trove today and Know Your World of technology!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs' site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.

Tags:

Yseop Veeva AI Medical Writing Regulatory Documents Life Sciences Drug Development

Join The Discussion

Software Development

Yseop Joins Veevas AI Partner Program To Accelerate Regulatory Document Writing And AI-Driven Content Automation

Join Our Newsletter